Next Generation mRNA Therapies Post COVID-19 with Jacob Becraft of Strand Therapeutics Artwork

The DeciBiome

Join the DeciBio team as they discuss industry news and hot topics in the precision medicine space with some of the brightest in the industry.

All Episodes

The DeciBiome

Next Generation mRNA Therapies Post COVID-19 with Jacob Becraft of Strand Therapeutics

June 21, 2022 • DeciBio • Episode 5

On this episode, Alex Amram and Joe Daccache interview special guest, Jacob Becraft the CEO and co-founder of Strand Therapeutics— a company leveraging synthetic biology to create the next-generation of messenger RNA (mRNA) therapeutics using a platform of programmable, precise, and multi-functional mRNAs through the implementation of genetic logic circuits and other genomic features.